Filing Details

Accession Number:
0001493152-22-019076
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-12 16:05:10
Reporting Period:
2022-07-08
Accepted Time:
2022-07-12 16:05:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552189 Panacea Life Sciences Holdings Inc. PLSH Medicinal Chemicals & Botanical Products (2833) 271085858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1866792 Leslie Buttorff 5910 South University Blvd, C18-193
Greenwood Village CO 80121
Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-08 1,600 $0.20 621,049 No 4 P Direct
Common Stock Acquisiton 2022-07-08 2,500 $0.16 623,549 No 4 P Direct
Common Stock Acquisiton 2022-07-11 1,000 $0.39 624,549 No 4 P Direct
Common Stock Acquisiton 2022-07-11 500 $0.50 625,049 No 4 P Direct
Common Stock Acquisiton 2022-07-11 2,100 $0.40 627,149 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,047,054 Indirect Held by Quintel-MC, Incorporated
Series C Preferred Stock 1,000,000 Indirect Held by Quintel-MC, Incorporated
Series C-1 Preferred Stock 10,000 Indirect Held by Quintel-MC, Incorporated
Series C-2 Preferred Stock 100 Indirect Held by Quintel-MC, Incorporated
Series D Preferred Stock 10,000 Indirect Held by J&N Real Estate Company LLC